Home

NEA Partners 16, L.P.

CIK 1712881 · last filed 2024-12-23

NEA Partners 16, L.P. is a corporate insider who has filed 11 SEC Form 4 insider transactions across 7 companies since 2019. The most recent filing shows the insider bought $17.7M of MRKR on Dec 23, 2024. Across all open-market trades the lifetime net is +$220.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $503.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$503.04M

Companies

7

Total Filings

11

Lifetime Open-Market Net

$220.52M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MRKR 10%+ Owner 1,625,678 $1.18 $1.92M $47.74M 2 2024-12-23
NeueHealth, Inc. (NEUE) Delisted 10%+ Owner — $6.75 — $0 1 2024-10-03
Akouos, Inc. (AKUS) Delisted 10%+ Owner 0 $13.29 $0 $0 1 2022-12-02
GENOCEA BIOSCIENCES, INC. (GNCA) Delisted 10%+ Owner 4,445,093 $0.00 $2.7K $49.02M 3 2022-05-26
Metacrine, Inc. (MTCR) Delisted 10%+ Owner 2,563,257 $0.49 $1.27M $28.52M 2 2021-12-27
MIRM 10%+ Owner 3,736,243 $112.23 $419.32M $20.25M 1 2019-07-24
TRVI 10%+ Owner 4,438,562 $18.43 $81.80M $75.00M 1 2019-05-13

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-12-23 MRKR Buy (P) +5,542,500 $17.74M EDGAR
2024-10-03 NeueHealth, Inc. (NEUE) Delisted Buy (P) — $0 EDGAR
2022-12-02 Akouos, Inc. (AKUS) Delisted U −12,882,621 $0 EDGAR
2022-05-26 GENOCEA BIOSCIENCES, INC. (GNCA) Delisted Sell (S) −31,130,808 -$2.25M EDGAR
2021-12-27 Metacrine, Inc. (MTCR) Delisted Sell (S) −1,491,810 -$1.48M EDGAR
2021-03-18 MRKR Buy (P) +17,142,855 $30.00M EDGAR
2020-09-22 Metacrine, Inc. (MTCR) Delisted Mixed +9,181,581 $30.00M EDGAR
2020-07-28 GENOCEA BIOSCIENCES, INC. (GNCA) Delisted Buy (P) +9,453,780 $21.27M EDGAR
2019-07-24 MIRM Mixed +12,558,729 $20.25M EDGAR
2019-06-25 GENOCEA BIOSCIENCES, INC. (GNCA) Delisted Buy (P) +8,571,426 $30.00M EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.